302 related articles for article (PubMed ID: 33289661)
1. Broad transcriptional response of the human esophageal epithelium to proton pump inhibitors.
Rochman M; Xie YM; Mack L; Caldwell JM; Klingler AM; Osswald GA; Azouz NP; Rothenberg ME
J Allergy Clin Immunol; 2021 May; 147(5):1924-1935. PubMed ID: 33289661
[TBL] [Abstract][Full Text] [Related]
2. In Esophageal Squamous Cells From Eosinophilic Esophagitis Patients, Th2 Cytokines Increase Eotaxin-3 Secretion Through Effects on Intracellular Calcium and a Non-Gastric Proton Pump.
Odiase E; Zhang X; Chang Y; Nelson M; Balaji U; Gu J; Zhang Q; Pan Z; Spechler SJ; Souza RF
Gastroenterology; 2021 May; 160(6):2072-2088.e6. PubMed ID: 33581123
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitors decrease eotaxin-3 expression in the proximal esophagus of children with esophageal eosinophilia.
Park JY; Zhang X; Nguyen N; Souza RF; Spechler SJ; Cheng E
PLoS One; 2014; 9(7):e101391. PubMed ID: 24988451
[TBL] [Abstract][Full Text] [Related]
4. JAK-STAT6 Pathway Inhibitors Block Eotaxin-3 Secretion by Epithelial Cells and Fibroblasts from Esophageal Eosinophilia Patients: Promising Agents to Improve Inflammation and Prevent Fibrosis in EoE.
Cheng E; Zhang X; Wilson KS; Wang DH; Park JY; Huo X; Yu C; Zhang Q; Spechler SJ; Souza RF
PLoS One; 2016; 11(6):e0157376. PubMed ID: 27310888
[TBL] [Abstract][Full Text] [Related]
5. Th2 cytokine signaling through IL-4Rα increases eotaxin-3 secretion and tension in human esophageal smooth muscle.
Nelson MR; Zhang X; Podgaetz E; Wang X; Zhang Q; Pan Z; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2024 Jan; 326(1):G38-G52. PubMed ID: 37933466
[TBL] [Abstract][Full Text] [Related]
6. Omeprazole blocks STAT6 binding to the eotaxin-3 promoter in eosinophilic esophagitis cells.
Zhang X; Cheng E; Huo X; Yu C; Zhang Q; Pham TH; Wang DH; Spechler SJ; Souza RF
PLoS One; 2012; 7(11):e50037. PubMed ID: 23185525
[TBL] [Abstract][Full Text] [Related]
7. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patients with eosinophilic oesophagitis and GORD.
Cheng E; Zhang X; Huo X; Yu C; Zhang Q; Wang DH; Spechler SJ; Souza RF
Gut; 2013 Jun; 62(6):824-32. PubMed ID: 22580413
[TBL] [Abstract][Full Text] [Related]
8. Epithelial overexpression of IL-33 induces eosinophilic esophagitis dependent on IL-13.
Masuda MY; Pyon GC; Luo H; LeSuer WE; Putikova A; Dao A; Ortiz DR; Schulze AR; Fritz N; Kobayashi T; Iijima K; Klein-Szanto AJ; Shimonosono M; Flashner S; Morimoto M; Pai RK; Rank MA; Nakagawa H; Kita H; Wright BL; Doyle AD
J Allergy Clin Immunol; 2024 May; 153(5):1355-1368. PubMed ID: 38310974
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors decrease eotaxin-3/CCL26 expression in patients with chronic rhinosinusitis with nasal polyps: Possible role of the nongastric H,K-ATPase.
Min JY; Ocampo CJ; Stevens WW; Price CPE; Thompson CF; Homma T; Huang JH; Norton JE; Suh LA; Pothoven KL; Conley DB; Welch KC; Shintani-Smith S; Peters AT; Grammer LC; Harris KE; Hulse KE; Kato A; Modyanov NN; Kern RC; Schleimer RP; Tan BK
J Allergy Clin Immunol; 2017 Jan; 139(1):130-141.e11. PubMed ID: 27717558
[TBL] [Abstract][Full Text] [Related]
10. Proton pump inhibitor-responsive oesophageal eosinophilia correlates with downregulation of eotaxin-3 and Th2 cytokines overexpression.
Molina-Infante J; Rivas MD; Hernandez-Alonso M; Vinagre-Rodríguez G; Mateos-Rodríguez JM; Dueñas-Sadornil C; Perez-Gallardo B; Ferrando-Lamana L; Fernandez-Gonzalez N; Bañares R; Zamorano J
Aliment Pharmacol Ther; 2014 Oct; 40(8):955-65. PubMed ID: 25112708
[TBL] [Abstract][Full Text] [Related]
11. CD73
Hara T; Kasagi Y; Wang J; Sasaki M; Aaron B; Karami A; Shimonosono M; Shimonosono R; Maekawa H; Dolinsky L; Wilkins B; Klein J; Wei J; Nunes K; Lynch K; Spergel JM; Hamilton KE; Ruffner MA; Karakasheva TA; Whelan KA; Nakagawa H; Muir AB
Cell Mol Gastroenterol Hepatol; 2022; 13(5):1449-1467. PubMed ID: 35108658
[TBL] [Abstract][Full Text] [Related]
12. Overlapping Transcriptional Profile in Proton Pump Inhibitor Responsive and Nonresponsive Eosinophilic Esophagitis.
Hamilton MJ; Muftah M; Goldin AH; Lo WK; Hsu Blatman KS; Chan WW; Srivastava A
Clin Transl Gastroenterol; 2022 Nov; 13(11):e00540. PubMed ID: 36201660
[TBL] [Abstract][Full Text] [Related]
13. Profound loss of esophageal tissue differentiation in patients with eosinophilic esophagitis.
Rochman M; Travers J; Miracle CE; Bedard MC; Wen T; Azouz NP; Caldwell JM; Kc K; Sherrill JD; Davis BP; Rymer JK; Kaufman KM; Aronow BJ; Rothenberg ME
J Allergy Clin Immunol; 2017 Sep; 140(3):738-749.e3. PubMed ID: 28104354
[TBL] [Abstract][Full Text] [Related]
14. Proton pump inhibitors partially restore mucosal integrity in patients with proton pump inhibitor-responsive esophageal eosinophilia but not eosinophilic esophagitis.
van Rhijn BD; Weijenborg PW; Verheij J; van den Bergh Weerman MA; Verseijden C; van den Wijngaard RM; de Jonge WJ; Smout AJ; Bredenoord AJ
Clin Gastroenterol Hepatol; 2014 Nov; 12(11):1815-23.e2. PubMed ID: 24657840
[TBL] [Abstract][Full Text] [Related]
15. IL-13-induced STAT3-dependent signaling networks regulate esophageal epithelial proliferation in eosinophilic esophagitis.
Marella S; Sharma A; Ganesan V; Ferrer-Torres D; Krempski JW; Idelman G; Clark S; Nasiri Z; Vanoni S; Zeng C; Dlugosz AA; Zhou H; Wang S; Doyle AD; Wright BL; Spence JR; Chehade M; Hogan SP
J Allergy Clin Immunol; 2023 Dec; 152(6):1550-1568. PubMed ID: 37652141
[TBL] [Abstract][Full Text] [Related]
16. Solute carrier family 9, subfamily A, member 3 (SLC9A3)/sodium-hydrogen exchanger member 3 (NHE3) dysregulation and dilated intercellular spaces in patients with eosinophilic esophagitis.
Zeng C; Vanoni S; Wu D; Caldwell JM; Wheeler JC; Arora K; Noah TK; Waggoner L; Besse JA; Yamani AN; Uddin J; Rochman M; Wen T; Chehade M; Collins MH; Mukkada VA; Putnam PE; Naren AP; Rothenberg ME; Hogan SP
J Allergy Clin Immunol; 2018 Dec; 142(6):1843-1855. PubMed ID: 29729938
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of six proton pump inhibitors as inhibitors of various human cytochromes P450: focus on cytochrome P450 2C19.
Zvyaga T; Chang SY; Chen C; Yang Z; Vuppugalla R; Hurley J; Thorndike D; Wagner A; Chimalakonda A; Rodrigues AD
Drug Metab Dispos; 2012 Sep; 40(9):1698-711. PubMed ID: 22648560
[TBL] [Abstract][Full Text] [Related]
18. Proton pump inhibitor-responsive oesophageal eosinophilia and eosinophilic oesophagitis: more similarities than differences.
Eluri S; Dellon ES
Curr Opin Gastroenterol; 2015 Jul; 31(4):309-15. PubMed ID: 26039722
[TBL] [Abstract][Full Text] [Related]
19. In oesophageal squamous cells exposed to acidic bile salt medium, omeprazole inhibits IL-8 expression through effects on nuclear factor-κB and activator protein-1.
Huo X; Zhang X; Yu C; Zhang Q; Cheng E; Wang DH; Pham TH; Spechler SJ; Souza RF
Gut; 2014 Jul; 63(7):1042-52. PubMed ID: 24048734
[TBL] [Abstract][Full Text] [Related]
20. Eosinophilic esophagitis after total gastrectomy treated with proton pump inhibitors: a case report.
Owaki T; Sato H; Horigome R; Hashimoto S; Honma T; Terai S
Clin J Gastroenterol; 2019 Oct; 12(5):420-423. PubMed ID: 30848447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
